Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma on Vimeo
NMD Pharma
Big deal: NMD flexes series A muscles - Global University Venturing
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma — NMD Pharma
Management — NMD Pharma
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma A/S | LinkedIn
NMD Pharma - Crunchbase Company Profile & Funding
Detailed Description | NMD-GPS
Erhverv Aarhus - 照片| Facebook
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma - Inkef capital
PDF) A missense mutation in the putative sarcoplasmic reticulum transmembrane protein DCST2 causes dominant strongman syndrome
NMD Pharma - PIR International
NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
Neuromuscular Drug Development Summit (NMD) - Pharma Journalist
NMD Pharma - Inkef capital
